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Accepted 11 November 2015Mycobacterium bovis bacille Calmette–Guerin (BCG) is being considered for vaccination of feral swine (Sus scrofa
ssp.). Since BCG is a live bacterium, evaluation of its safety and persistence in tissues is important. Fifteen feral
swine received approximately 4.5 × 106 colony forming units of BCG Danish via oral bait. Four animals received
bait without BCG. At 1, 3, 6, and 9 months post-vaccination, four vaccinates were euthanized. Non-vaccinates
were euthanized at 9 months. Clinical signs were not noted in vaccinated pigs at any time. Tissues from all 20
pigs were culture-negative for mycobacteria. Based on our data, BCG is safe and appears not to persist in feral
swine tissues after one month post-oral vaccination. However, further work must be performed at higher
doses, and on a larger number of animals representing the target population, and further evaluation of persis-
tence in tissues within the ﬁrst month post-vaccination is needed.
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Tissue persistenceBovine tuberculosis (bTB), caused byMycobacterium bovis, is present
in manywild swine populations throughout the world. Speciﬁcally, bTB
is present in wild boar (Sus scrofa) populations in Spain, France,
Portugal, United Kingdom, and Italy, and in feral swine (S. scrofa ssp.)
populations in New Zealand and Molokai Island, Hawaii, USA (Corner,
2006; Foyle et al., 2010; Freier et al., 2007; Hermoso de Mendoza
et al., 2006; Naranjo et al., 2008; Santos et al., 2009; Serraino et al.,
1999; Zanella et al., 2012). The maintenance of bTB in wild, free-
ranging populations poses a threat to domestic animal and human
health due to spill over events and possible hunter exposure.
Mycobacterium bovis bacille Calmette–Guerin (BCG) Danish strain,
administered orally at a dose of approximately 1 × 106 colony forming
units (cfu), has been shown to be effective in reducing infection and,
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, USA.disease progression in wild boar (Ballesteros et al., 2009a; Garrido
et al., 2011), and ﬁeld trials are underway to evaluate the efﬁcacy of
this vaccine in free-ranging animals. Therefore, BCG is being considered
for use in the management of bTB-infected feral swine. Feral swine are
hunted year-round in the state of Hawaii and it is thus important to
know whether BCG, a live attenuated bacterium, persists in feral
swine tissues, and could potentially be ingested by hunters if proper
cooking methods were not applied before consumption. The aim of
this study was to determinewhether BCG could be found in various tis-
sues, such as lymph nodes and muscle, of feral swine at various time
points post-vaccination.
Twenty, 8-month-old feral swine (11 females and 9males)were born
and raised in a breeding colony at the United States Department of Agri-
culture (USDA)/Colorado State University Wildlife Research Facility in
Fort Collins, Colorado, USA. The breeding herd consists of animals of
Texas origin or offspring thereof. Swine were held in an outdoor pen en-
vironment. The swine were randomly selected to be placed into a vacci-
nated group (n = 16) or a control group (n = 4). Animals in the
control group were held in a separate pen from vaccinates with no direct
contact. This animal study protocol was approved by Colorado State
University's Institutional Animal Care and Use Committee (Protocol #
11-2487A).
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vored bait described in Ballesteros et al. (2009b) with approximately
4.5 × 106 cfu of BCG Danish strain 1331. The BCG (5 × 107 cfu/ml
stock) was kindly provided by W. R. Waters and T. Thacker at the
USDA, Agricultural Research Service, National Animal Disease Center
in Ames, Iowa, USA. The BCG was prepared by incubation at 37 °C for
4 weeks in Middlebrook's 7H9 liquid media with 10% oleic albumin
dextrose citrate enrichment (Bacto Middlebrook OADC Enrichment,
DIFCO Laboratories, Detroit, Michigan, USA). The bacteria were
then harvested by centrifugation, and washed twice with 0.01 M
phosphate buffered saline (PBS), pH 7.4. After resuspension in PBS
solution, aliquots were stored at −80 °C until used. The frozen
stock was quantitated by serially diluting an aliquot in 7H9 followed
by plating on Middlebrook 7H10 agar supplemented with OADC. The
vaccine was diluted in Middlebrook 7H9/OADC media to a concen-
tration of 2.25 × 107 cfu/ml. A volume of 0.2 ml (approximately
4.5 × 106 cfu) vaccine was aliquoted into 0.5 ml centrifuge tubes.
Each centrifuge tube was embedded within a bait. A single bait was
hand fed to each individual animal. Each of the four controls was
fed bait containing media alone without vaccine.
At 1, 3, 6, and 9months post-vaccination, 4 vaccinated animals were
randomly chosen for euthanasia. At 9 months, the control animals were
euthanized. The following tissueswere collected at necropsy for cultural
analysis and histologic analysis as needed: submandibular lymph nodes
(lnn), parotid lnn, medial retropharyngeal lnn, tonsil, mediastinal lnn,
tracheobronchial lnn, sternal ln, hepatic lnn, mesenteric lnn, iliac lnn,
superﬁcial inguinal lnn, popliteal lnn, liver, heart, kidney, lung, and the
following muscle tissues: epaxial, sublumbar, shoulder (supraspinatus
and triceps muscles), and thigh (semimembranosus, semitendinosus
and biceps femoris muscles).
Tissues were collected in 10% neutral buffered formalin for histopa-
thology. Tissues for mycobacterial culture were collected in Whirl Pak®
(Nasco, Fort Atkinson, Wisconsin, USA) bags and stored at−70 °C until
testing at the USDA, Animal and Plant Health Inspection Service, National
Veterinary Services Laboratories, Ames, Iowa, USA. Tissues were pooled
into seven pools per animal: head pool (retropharyngeal lnn, parotid
lnn, tonsil, submandibular lnn), thoracic pool (mediastinal lnn, tracheo-
bronchial lnn, sternal ln), abdominal pool (gastrohepatic lnn, mesenteric
lnn, iliac lnn, superﬁcial inguinal lnn), back muscle pool (sublumbar,
epaxial), thigh muscle pool (semimembranosus, semitendinosus, biceps
femoris), shoulder muscle pool (supraspinatus, triceps), and organ pool
(liver, kidney). Mycobacterial cultures were performed as previously de-
scribed (Robbe-Austerman et al., 2013). Brieﬂy, tissues were trimmed,
50–60 g of tissue was homogenized in 200 ml of phenol red broth and
decontaminated with 4% NaOH for 10 min. Once samples were neutral-
izedwith 6%HCl, theywere centrifuged at 4600×g and the pellet was in-
oculated into both BACTEC MGIT media and BACTEC 460 12b media.
Media were incubated according to manufacturer's recommendations,
and signal positive tubes or bottles were examined for the presence of
acid fast bacteria. If the media signaled positive prior to 42 days and no
acid fast organisms were detected, they were incubated at 37 °C for the
full 42 days before being restained. All media signaling positive prior to
the 42 day incubation where acid fast organisms were not recovered
were considered contaminated.
All but one of the 16 vaccinates consumed the vaccine. This animal
could not be identiﬁed because one vial containing vaccine was spit
out at an unknown time and was found later on the ground. There
were no signiﬁcant ﬁndings on necropsy, all tissues examined appeared
grossly normal. None of the tissue pools cultured grew any
mycobacteria. Approximately 15.7% (22/140 pools tested) of the tissue
pools were contaminated. Three animals (all vaccinates) had between
three and ﬁve contaminated samples, three animals had two contami-
nated samples (1 control and 2 vaccinates), and two animals had one
contaminated sample associated with them (both vaccinates). Ten of
22 contaminated samples (45%) were muscle pools, seven were head
pools (31.8%), three were abdominal pools (13.6%), one was a thoracicpool (4.5%), and one was an organ pool (4.5%). Based on the lack of
gross lesions and lack ofMycobacterium recovery, tissues were not ex-
amined histopathologically.
Wewere not able to detect BCG in feral swine tissues after 1, 3, 6, and
9 months post-oral vaccination. This is consistent with previous wild
boar studies inwhich animalswere vaccinatedwithBCGDanish ranging
from 1× 105 to 1 × 106 cfu of BCG. BCG could not be recovered from any
of the tissues between 6 and 10 months after vaccination (Ballesteros
et al., 2009a; Garrido et al., 2011; Gortazar et al., 2014). In addition, no
abnormal clinical signs or gross lesions were noted. Based on these re-
sults, it is likely that BCG does not persist in swine tissues at detectible
levels after one month post oral vaccination at the discussed dose
rates. Oral BCG does not appear to cause visible adverse effects in this
limited study.
In contrast, greater persistence does occur in non-suid species, and it
should be noted that effective oral dose rates in these species are greater
than those used in the current study. Studies in both monogastric and
ruminant species have shown that BCG can persist from two to several
months in various tissues depending on strain, dose, and route of deliv-
ery. In white-tailed deer, BCG Danish can persist in lymph nodes from
three to twelvemonths at doses ranging from 1 × 108 to 1 × 109 cfu, de-
pending on whether the vaccine was administered orally or subcutane-
ously, the subcutaneous route creating the longer persistence times
(Nol et al., 2013; Palmer et al., 2009, 2014). In addition, Pasteur strain
BCG administered subcutaneously to white-tailed deer has been
shown to persist in lymph nodes for over 8 months (Palmer et al.,
2009) and can be shed to other animals (Palmer et al., 2009). Red deer
retained BCG Pasteur at injection sites and draining lymph nodes up
to fourteen weeks after subcutaneous vaccination of 2 × 106 cfu
(Slobbe et al., 1999). In brushtail possums (Trichosurus vulpecula), BCG
remained in speciﬁc lymph nodes for up to 8 weeks after oral vaccina-
tion with 1 × 108 cfu (Wedlock et al., 2005). In contrast, studies in
mice have demonstrated persistence for up to 30 weeks after subcuta-
neous vaccination as well as after oral administration of lipid-
encapsulated BCG Pasteur. However, a non-encapsulated form of oral
BCG only persisted for up to twelve weeks in mice (Aldwell et al.,
2006).More studies need to be performed in order to further investigate
persistence in different strains of feral swine at different target age clas-
ses and at dose rates similar to and higher than that studied here. These
trials would then need to be repeated in the chosen vaccine delivery ve-
hicle in order to determine any changes in persistence that might be
caused by the delivery matrix.
Muscle and head pools were the most likely tissue samples to be
contaminated in this study. This was possibly due to the relatively
large amount of and number of tissues cultured per pool, increasing
the likelihood of contamination. A liquid media protocol involving two
commercial media formulations was used to increase the likelihood of
successfully culturing BCG, and this laboratory has successfully cultured
BCG in vaccine persistence studies previously. Thereforewe believe that
we would have detected BCG had it been present. However, in future
work, collections and culture methods should be modiﬁed to mitigate
contamination issues by reducing pool size and sample mass.
If BCG were to be proposed for a ﬁeld trial in feral swine in the
United States, further investigations need to be performed focusing
on safety and efﬁcacy on a larger sample size in animals from the tar-
get population. These investigations must test appropriate age clas-
ses that are thought to contribute to the epidemiology of bovine
tuberculosis in a particular region. In addition, the time frame for
testing needs to be modiﬁed in order to determine the presence of
BCG in tissues within the ﬁrst month after vaccination as well as
fecal and oral shedding.
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